Anti-Bacillus anthracis protective antigen antibody
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Polyclonal Bacillus anthracis protective antigen antibody. Suitable for WB and reacts with Recombinant fragment - Bacillus anthracis samples. Cited in 8 publications.
View Alternative Names
pag, pXO1-110, BXA0164, GBAA_pXO1_0164, pagA, Protective antigen, PA, Anthrax toxins translocating protein, PA-83, PA83
- WB
Unknown
Western blot - Anti-Bacillus anthracis protective antigen antibody (AB13808)
Western blot analysis of Anthrax PA in recombinant protein using ab13808 (lane B) at 1 : 1000 dilution. Lane A shows the pre-bleed.
All lanes:
Western blot - Anti-Bacillus anthracis protective antigen antibody (ab13808)
false
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bacillus anthracis protective antigen behaves as a part of a complex specifically the anthrax toxin composed of LF EF and PA itself. PA binds to host cell’s receptors such as ANTXR1 and ANTXR2. Once PA attaches to these receptors it undergoes proteolytic cleavage to heptamer formation allowing the assembly of the toxin complex. This heptamer serves as a platform for LF and EF which subsequently translocate into the host cell's cytosol disrupting cellular processes and immune responses.
Pathways
Bacillus anthracis protective antigen operates primarily in endocytic and intracellular trafficking pathways. The binding and cleavage of PA on the host cell surface enable endocytosis of the toxin complex through clathrin-mediated pathways. This interaction with cellular components is critical for facilitating the entry of LF and EF which relate to pathways involving cellular signaling and immune response suppression. These processes highlight PA’s role in efficiently hijacking host cellular machinery for pathogenic activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Virus genes 61:342-354 PubMed40159353
2025
Applications
Unspecified application
Species
Unspecified reactive species
Microbiology spectrum 12:e0378623 PubMed38899864
2024
Applications
Unspecified application
Species
Unspecified reactive species
Analytical chemistry 92:7845-7851 PubMed32437125
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bacteriology 202: PubMed32071095
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of controlled release : official journal of the Controlled Release Society 220:316-328 PubMed26546271
2015
Applications
Unspecified application
Species
Unspecified reactive species
Letters in applied microbiology 54:306-12 PubMed22268495
2012
Applications
Unspecified application
Species
Unspecified reactive species
Infection and immunity 79:3012-9 PubMed21576337
2011
Applications
WB
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 107:15583-8 PubMed20713715
2010
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com